•  
  •  
  •  
  •  

2025-12-23 12:37:57

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE154U01015

Stock Report

  • Max Estates' first luxury residential project in NCR garners pre-formal launch sales of INR 1,800+ crores
  • Max Estates receives NCLT Order for Delhi One
  • Max Estates enters Gurugram Residential Real Estate market with development potential of ~2.4 mn. sq. ft.
  • Max Estates completes acquisition of stake in Acreage Builders Pvt Ltd
  • Max Estates receives confirmation from Axis Bank as the successful bidder for land parcels in Sector 129, Noida
  • Max Estates Ltd completes acquisition of 100% in Accord Hotels and Resorts Pvt Ltd
  • Max Estates acquires ~10 acres of mixed use residential land parcel in Noida
  • Max Estates Ltd to acquire 100%in Accord Hotels and Resorts Pvt Ltd
  • Max House Phase 1 in Okhla 100% leased out to marquee corporates
  • MaxVIL completes closing of 1st tranche of the divestment of balance 51% stake in its packaging business
  • Max Ventures & Industries Ltd to emerge as pure-play real estate business entity

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024